Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Ole J Storebø, Erik Simonsen, Christian Gluud

27 Citationer (Scopus)

Abstract

Clinical Question: Is treatment with methylphenidate associated with benefits or harms for children and adolescents with attention-deficit/hyperactivity disorder (ADHD)?

Bottom Line: Methylphenidate is associated with improvement in ADHD symptoms, general behavior, and quality of life; however, due to the very low quality of the evidence, the magnitude of the associated improvement is uncertain. Methylphenidate was associated with an increased risk of nonserious adverse events. There are too few data to assess the association with serious adverse events.

OriginalsprogEngelsk
TidsskriftJ A M A: The Journal of the American Medical Association
Vol/bind315
Udgave nummer18
Sider (fra-til)2009-2010
Antal sider2
ISSN0098-7484
DOI
StatusUdgivet - 10 maj 2016

Fingeraftryk

Dyk ned i forskningsemnerne om 'Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents'. Sammen danner de et unikt fingeraftryk.

Citationsformater